Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer

Androgen deprivation therapy (ADT) is a systemic therapy for advanced prostate cancer (PCa). Although most patients initially respond to ADT, almost all cancers eventually develop castration resistance. Castration-resistant PCa (CRPC) is associated with a very poor prognosis, and the treatment of wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Shangwei, Peng, Shoujiao, Chen, Zihua, Chen, Zhikang, Luo, Jun-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950316/
https://www.ncbi.nlm.nih.gov/pubmed/35335873
http://dx.doi.org/10.3390/pharmaceutics14030498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950316/
https://www.ncbi.nlm.nih.gov/pubmed/35335873
http://dx.doi.org/10.3390/pharmaceutics14030498

Ejemplares similares